Terminology Service for NFDI4Health
All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Intracellular Signaling Process | NCIT_C21040 | [Any subcellular process that is initated by a chemical or mechanical stimulus and results in a specific cellular response.] |
| Biochemical Process | NCIT_C28498 | [A linked series of non-equivalent biochemical interactions and enzymatic reactions, and/or a linked series of biochemical processes.] |
| SELP Gene | NCIT_C21041 | [This gene plays a role in cellular adhesion and mediates immune and endothelial cell interactions.] |
| Atopy | NCIT_C41366 | [A genetic predisposition to form IgE antibodies in response to exposure to allergens and therefore, for the development of immediate (type I) hypersensitivity and atopic conditions, such as allergic rhinitis; bronchial asthma, atopic dermatitis, and food allergy. Mutations of specific alleles on the long arm of chromosome 5 have been associated with higher levels of IL-4 and IgE and are known as IL-4 promoter polymorphisms.] |
| Cell-Matrix Adhesion Process | NCIT_C20191 | [Any cellular process in which a cell attaches to the extracellular matrix via adhesion molecules.] |
| Group Therapy | NCIT_C21042 | [A form of psychiatric treatment in which six to eight patients meet a specific number of times with a therapist. The value of this type of therapy is the opportunity for gaining insight from others into one's life experience. (Taber's)] |
| Psychotherapy | NCIT_C15308 | [A method of treating disease, esp. psychic disorders, by mental rather than pharmacological means (e.g., suggestion, re-education, hypnotism, and psychoanalysis). (Taber's)] |
| Stage IVB Major Salivary Gland Cancer AJCC v7 | NCIT_C35695 | [Stage IVB includes: (T4b, Any N, M0); (Any T, N3, M0). T4b: Very advanced disease. Tumor invades skull base and/or pterygoid plates and/or encases carotid artery. N3: Metastasis in a lymph node, more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.)] |
| Stage IV Major Salivary Gland Cancer AJCC v7 | NCIT_C5898 | [Stage IV includes: IVA (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB (T4b, Any N, M0); (Any T, N3, M0); IVC (Any T, Any N, M1). T4a: Moderately advanced disease. Tumor invades skin, mandible, ear canal, and/or facial nerve. T1: Tumor measuring 2 cm or less in greatest dimension without extraparenchymal extension. Extraparenchymal extension is clinical or macroscopic evidence of invasion of soft tissues. Microscopic evidence alone does not constitute extraparenchymal extension for classification purposes. T2: Tumor measuring more than 2 cm, but not more than 4 cm in greatest dimension without extraparenchymal extension. T3: Tumor measuring more than 4 cm in greatest dimension, and/or tumor having extraparenchymal extension. T4b: Very advanced disease. Tumor invades skull base and/or pterygoid plates and/or encases carotid artery. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Metastasis in a lymph node, more than 6 cm in greatest dimension. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.)] |
| C-Reactive Protein | NCIT_C60651 | [C-reactive protein (224 aa, ~25 kDa) is encoded by the human CRP gene. This protein is cleaved during biological activation and is associated with host defense mechanisms and inflammatory responses.] |
| Immunoprotein | NCIT_C16725 | [A protein whose activities affect or play a role in immune system functions.] |
| Stage IVC Major Salivary Gland Cancer AJCC v7 | NCIT_C35696 | [Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.)] |
| DAPK1 Gene | NCIT_C60652 | [This gene is involved in pro-apoptotic regulation.] |
| Serine/Threonine Protein Kinase Gene | NCIT_C25873 | [Serine/Threonine Protein Kinase Genes encode enzymes (Serine/Threonine Protein Kinases) that catalyze phosphorylation of serine or threonine residues in proteins, with ATP or other nucleotides as phosphate donors. (NCI)] |
| Positive Regulation of Apoptosis | NCIT_C20150 | [Any cellular process that increases the frequency, rate or extent of cell death by apoptosis.] |
| Serine/Threonine Phosphorylation | NCIT_C20679 | [Serine/Threonine Phosphorylation involves covalent linkage of a phosphate group (from a donor compound such as ATP) with a serine or threonine residue of a Protein Kinase acceptor, often as a mechanism of kinase activity regulation.] |
| Tumor Suppression | NCIT_C26040 | [Tumor suppression involves inhibition of tumor cell growth, proliferation, malignancy, or metastasis.] |
| Epiglottic Carcinoma | NCIT_C35697 | [A carcinoma of the larynx that arises from the epiglottis.] |
| Supraglottic Carcinoma | NCIT_C5973 | [A carcinoma of the larynx that arises from the supraglottic area.] |
| Malignant Epiglottis Neoplasm | NCIT_C4836 | [A malignant neoplasm that affects the epiglottis. The vast majority of cases are squamous cell carcinomas.] |